Therefore, this study investigated the expression levels of PARP3 mRNA in AML patients and normal samples from the TCGA and GEO databases, analyzed the correlations between PARP3 expression levels and clinical characteristics, and elucidated the prognostic value of PARP3 expression in AML. This evidence concerns the gene PARP3 and acute myeloid leukemia.